Literature DB >> 6893485

Congenital anomalies in children of epileptic mothers and fathers.

E Dieterich, A Steveling, A Lukas, N Seyfeddinipur, J Spranger.   

Abstract

Children of epileptic mothers have a higher risk for major malformations. A similar increase of major malformations is observed in children of epileptic fathers suggesting that the major malformations are related to the parental disease rather than to the antiepileptic drug. No information was available if the pattern of minor acrofacial malformations known as the "hydantoin syndrome" occurs also in children of epileptic fathers. We studied 37 children of treated mothers and 22 children of treated fathers with epilepsy. No major malformations were observed. The typical acrofacial syndrome occurred only in children of epileptic mothers suggesting that this characteristic syndrome is drug-related. Major malformations and the syndrome of minor acrofacial anomalies seem to have a different etiology. Since the pattern of minor acrofacial anomalies occurs after exposure to anticonvulsants other than hydantoin the term "antiepileptica syndrome" should be used for this particular embryopathy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6893485     DOI: 10.1055/s-2008-1071396

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  8 in total

Review 1.  Medical genetics: 1. Clinical teratology in the age of genomics.

Authors:  Janine E Polifka; J M Friedman
Journal:  CMAJ       Date:  2002-08-06       Impact factor: 8.262

2.  Fetal valproate syndrome.

Authors:  J Clayton-Smith; D Donnai
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

3.  Reduction in valproic acid-induced neural tube defects by maternal immune stimulation: role of apoptosis.

Authors:  Mural Mallela; Theresa Hrubec
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2012-07-05

4.  An anomalous left superior venacava draining into left atrium in association with fetal valproate syndrome.

Authors:  Suman Sarkar; Shyamal Kumar Sardar; Dinesh Munian; Subham Bhattacharya; Bhuban Majhi
Journal:  Indian J Pediatr       Date:  2012-06-08       Impact factor: 1.967

5.  Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes.

Authors:  U Kini; N Adab; J Vinten; A Fryer; J Clayton-Smith
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-10-20       Impact factor: 5.747

6.  Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.

Authors:  E Thisted; F Ebbesen
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

7.  Valproic acid increases expression of methylenetetrahydrofolate reductase (MTHFR) and induces lower teratogenicity in MTHFR deficiency.

Authors:  Marc Roy; Daniel Leclerc; Qing Wu; Sapna Gupta; Warren D Kruger; Rima Rozen
Journal:  J Cell Biochem       Date:  2008-10-01       Impact factor: 4.429

8.  Fetal valproate syndrome.

Authors:  Parmarth G Chandane; Ira Shah
Journal:  Indian J Hum Genet       Date:  2014-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.